Blue Trust Inc’s Legend Biotech LEGN Stock Holding History

Blue Trust Inc’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$60	Sell	3 -80	-96%	-$1.71K	﹤0.01%	2458
2026 Q2	$2.4K	Buy	+83	New	+$2.24K	﹤0.01%	2152
2025 Q4	–	Sell	-33	Closed	-$1.08K	–	2650
2025 Q3	$1.08K	Hold	33	–	–	﹤0.01%	2306
2025 Q2	$1.17K	Sell	33 -331	-91%	-$10.7K	﹤0.01%	2221
2025 Q1	$12.4K	Buy	364 +43	+13%	+$1.54K	﹤0.01%	1808
2024 Q4	$10.4K	Sell	321 -41	-11%	-$1.7K	﹤0.01%	1825
2024 Q3	$16K	Sell	362 -452	-56%	-$24.1K	﹤0.01%	2032
2024 Q2	$45.7K	Buy	814 +806	+10,075%	+$37.2K	﹤0.01%	1290
2024 Q1	$449	Sell	8 -211	-96%	-$12.7K	﹤0.01%	2020
2023 Q4	$14K	Buy	219 +199	+995%	+$12.6K	﹤0.01%	1453
2023 Q3	$1K	Buy	+20	New	+$1.39K	﹤0.01%	1931
2023 Q2	–	Sell	-193	Closed	-$10K	–	2307
2023 Q1	$10K	Buy	193 +85	+79%	+$4.16K	﹤0.01%	1606
2022 Q4	$5K	Buy	+108	New	+$5.23K	﹤0.01%	1728

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Matthews International Capital Management San Francisco, California $241M AUM 42.66% 1-Year Est. Return

Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

IAMH

IvyRock Asset Management (HK) Sheung Wan, Hong Kong $190M AUM 21.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Blue Trust Inc's LEGN Position: Q3 2026 in Review

Blue Trust Inc reduced its Legend Biotech (LEGN) stake by 96% in Q3 2026, selling an estimated $1.71K and leaving 3 shares worth $60. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

Blue Trust Inc first reported a position in LEGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $45.7K in Q2 2024. 118 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

Blue Trust Inc held 3 shares of Legend Biotech worth $60 as of Q3 2026.
Blue Trust Inc sold 80 Legend Biotech shares in Q3 2026, an estimated $1.71K.
Legend Biotech made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #2458 holding.
Blue Trust Inc first reported a position in Legend Biotech in Q4 2022 and has held it in 13 quarters since.
Blue Trust Inc's Legend Biotech position peaked at $45.7K in Q2 2024.
118 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.